Subscribe
shutterstock_1397823584_pavel_kapysh
Pavel Kapysh / Shutterstock.com
30 November 2021AmericasMuireann Bolger

Biofrontera settles patent dispute with Dusa over skin treatment

A US subsidiary of German skin treatment company Biofrontera has resolved its dispute with Dusa Pharmaceuticals, on the eve of a trial over patents covering a light therapy used to treat skin conditions, called BLU-U.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Aurobindo sued by Pfizer over skin antibiotic
4 July 2014   Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections.
Americas
Genentech hits Eli Lilly with skin treatment claim
4 July 2018   Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Aurobindo sued by Pfizer over skin antibiotic
4 July 2014   Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections.
Americas
Genentech hits Eli Lilly with skin treatment claim
4 July 2018   Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.

More on this story

Americas
Aurobindo sued by Pfizer over skin antibiotic
4 July 2014   Pfizer has launched a lawsuit against Aurobindo Pharma accusing the Indian pharmaceutical company of infringing patents related to an antibiotic used to treat skin infections.
Americas
Genentech hits Eli Lilly with skin treatment claim
4 July 2018   Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent